ArticleOncotarget2014
A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin's lymphoma.
Vivek Subbiah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleOncotarget2014
Vivek Subbiah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.